On 8 August 2000, orphan designation (EU/3/00/001) was granted by the European Commission to Ares-Serono (Europe) Ltd., United Kingdom, for somatropin for AIDS wasting.
The sponsorship was transferred to Serono Europe Limited, United Kingdom, in May 2002. The name of the sponsor changed to Merck Serono Europe Limited in November 2009.
Please note that this product was withdrawn from the Union Register of orphan medicinal products in October 2020 on request of the Sponsor.
|Disease / condition||
|Date of first decision||
|EU designation number||
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.